needed effects
peginterferon alfa-b
unwanted side effects
medical attention
following side effects
taking peginterferon alfa-b
check
doctor
peginterferon
alfa-b side effects
medical attention
body
medicine
side effects
health care professional
side effects
following side effects
study patients
least side effect
common side effects
product
treatment of chronic hepatitis c
chc
ribavirin
headache
myalgia
fatigue/asthenia
injection site inflammation/reaction
emotional lability/irritability
nausea
rigors
fevers
chills
insomnia
anemia
alopecia
anorexia
weight loss
rash
peginterferon alfa-b/ribavirin
serious side effects
drug
ribavirin
subjects during clinical trials
common serious side effects
peginterferon alfa-b/ribavirin
depression
suicidal ideation in less
subjects
common fatal side effects
combination
cardiac arrest
suicidal ideation
suicide attempt in less
subjects
most cases
side effects
discontinuation of therapy
clinical trials
chc patients
discontinued therapy
side effects
common side effects
product
adjuvant treatment of melanoma
fatigue
alt
ast
pyrexia
headache
anorexia
myalgia
nausea
chills
injection site reaction
common serious side effects
fatigue
alt
ast
pyrexia
clinical trial
melanoma patients
discontinued therapy
side effects
decreased neutrophil counts
ribavirin
anemia
ribavirin
neutropenia
ribavirin
thrombocytopenia
ribavirin
leukopenia
ribavirin
chc patients
grade
grade neutropenia
hemoglobin levels below g/l
peginterferon alfa-b/ribavirin
granulocytopenia
x
l
patients
mcg/kg of peginterferon alfa-b
thrombocytopenia
x
l
patients
mcg/kg of peginterferon alfa-b
neutropenia
thrombocytopenia
anemia
hepatitis c virus
hcv
hiv-coinfected patients
neutropenia
absolute neutrophil count levels
cells/mm
platelets
mm
anemia
hemoglobin
g/dl
cd lymphocytes
hcv/hiv-coinfected patients
receiving peginterferon alfa-b/ribavirin
anemia
grades
grade
melanoma patients
year-old patient with multiple myeloma
severe bone marrow hypoplasia
peginterferon
alfa-b therapy
patient
taking
taking oral thalidomide for several months
adding peginterferon alfa-b
regimen
severe bone marrow hypoplasia
using
drugs
thalidomide
agent
peginterferon alfa-b
myelosuppression
possible interaction between thalidomide
interferon alfa-b
chc patients
decreased neutrophil counts
hemoglobin levels
platelet counts
anemia
neutropenia
granulocytopenia
thrombocytopenia
leukopenia
hemolytic anemia
lymphadenopathy
cd lymphocytes-uncommon
autoimmune thrombocytopenia
purpura
aplastic anemia-frequency
hemolysis-postmarketing reports
pure red cell aplasia
idiopathic thrombocytopenic purpura
thrombotic thrombocytopenic purpuramelanoma patients
anemia-frequency
severe bone marrow hypoplasia
headache
ribavirin
dizziness
ribavirin
taste perversion
ribavirin
chc patients
paresthesia
hcv/hiv-coinfected patients
receiving peginterferon alfa-b/ribavirin
vertigo
migraine headache
paresthesia
hearing impairment
hearing loss
encephalopathy
peripheral neuropathy
postmarketing experience
headache
grades
grade
dysgeusia
grades
dizziness
grades
grade
olfactory nerve disorder
grades
paresthesia
grades
grade
melanoma patients
chc patients
headache
dizziness
hypertonia
taste perversion
amnesia
memory impairment
syncope
migraine
ataxia
confusion
neuralgia
paresthesia
hypoesthesia
hyperesthesia
somnolence
disturbance in attention
tremor
dysgeusia
hearing impairment/loss
tinnitus
nerve palsy
oculomotor
transient ischemic attack
loss of consciousness
neuropathy
peripheral neuropathy-rare
convulsion-very
cerebrovascular hemorrhage
cerebrovascular ischemia
encephalopathy-frequency
mononeuropathies
hearing/vestibular disorders-postmarketing reports
seizures
memory lossmelanoma patients
headache
dysgeusia
dizziness
olfactory nerve disorder
paresthesia
chc patients
anxiety/emotional lability/irritability
insomnia
depression
impaired concentration
nervousness
agitation
aggression
anger
altered mood
abnormal behavior
disorder
libido
apathy
abnormal dreams
fatal neuropsychiatric events
including suicide
suicide attempt
homicidal ideation
severe depression
psychosis
aggressive reaction
relapse of drug addiction/overdose
hallucinations
panic attack-rare
bipolar disorders-postmarketing reports
homicidal ideation
aggressive behavior
others
maniamelanoma patients
depression
anxiety/emotional lability/irritability
ribavirin
insomnia
ribavirin
depression
ribavirin
impaired concentration
ribavirin
agitation
ribavirin
nervousness
ribavirin
chc patients
fatal neuropsychiatric events
chc patients
previous psychiatric disorder
psychosis
hallucinations
patients
alpha interferons
psychoses
hallucinations
bipolar disorders
postmarketing experience
depression
grades
grade
melanoma patients
fatigue/asthenia
ribavirin
rigors
ribavirin
fever
ribavirin
chills
ribavirin
weight decrease
ribavirin
unspecified pain
ribavirin
right upper quadrant pain
ribavirin
viral infections
ribavirin
malaise
ribavirin
chest pain
ribavirin
flushing
ribavirin
fungal infections
ribavirin
chc patients
influenza-like symptoms
severity as treatment
bacterial infection
including sepsis
postmarketing experience
fatigue
grades
grade
pyrexia
grades
grade
chills
grades
grade
weight
grades
grade
melanoma patients
chc patients
fatigue/asthenia
rigors
influenza-like symptoms/illness
fever/pyrexia
chills
weight decrease
unspecified pain
right upper quadrant pain
viral infections
chest pain
malaise
flushing
bacterial infection
including sepsis
fungal infections
otitis media
breast pain
chest discomfort
face edema
peripheral edema
feeling
infection
sepsis
pneumonia
abscess
cellulitis
ear pain-postmarketing reports
asthenic conditions
including asthenia
malaise
fatigue
melanoma patients
fatigue
pyrexia
chills
weight
chc patients
myalgia
arthralgia
musculoskeletal pain
arthritis
pain
muscle spasms
pain in extremity
pain in limb-uncommon
gout
rheumatoid arthritis
bone pain
muscle weakness-rare
rhabdomyolysis
myositismelanoma patients
myalgia
arthralgia
myalgia
ribavirin
arthralgia
ribavirin
musculoskeletal pain
ribavirin
chc patients
pain in limb
pain
hcv/hiv-coinfected patients
receiving peginterferon alfa-b/ribavirin
small number of patients
moderate gout
rhabdomyolysis
myositis
rheumatoid arthritis
postmarketing experience
myalgia
grades
grade
arthralgia
grades
grade
melanoma patients
chc patients
injection site inflammation/reaction
including bruise
itchiness
irritation
injection site
injection site necrosis
injection site infection-frequency
localized skin ulcerations
subcutaneous
im injection
melanoma patients
injection site reaction
injection site inflammation/reaction
including bruise
itchiness
irritation
ribavirin
chc patients
injection site reaction
grades
grade
melanoma patients
chc patients
nausea
diarrhea
abdominal pain
vomiting
oral candidiasis
dry mouth
dyspepsia
constipation
gastroesophageal reflux disease
stomatitis
mouth ulceration
glossodynia
gingival bleeding
flatulence
hemorrhoids
cheilitis
abdominal distension
gingivitis
glossitis
tooth disorder
increased blood amylase
lipase
loose stools
ulcerative stomatitis-uncommon
gastroenteritis
pancreatitis
oral pain-rare
ulcerative colitis-frequency
hemorrhagic colitis
tongue pigmentation
tooth disorder
tooth
fracture-postmarketing reports
aphthous stomatitis
colitismelanoma patients
nausea
diarrhea
vomiting
nausea
ribavirin
diarrhea
ribavirin
abdominal pain
ribavirin
vomiting
ribavirin
dry mouth
ribavirin
dyspepsia
ribavirin
constipation
ribavirin
chc patients
oral candidiasis
increased blood amylase
lipase
hcv/hiv-coinfected patients
receiving peginterferon alfa-b/ribavirin
hemorrhagic/ischemic colitis
first months of alpha interferon therapy
pancreatitis
use of alpha interferon therapy
pancreatitis
postmarketing experience
nausea
grades
grade
diarrhea
grades
grade
vomiting
grades
grade
melanoma patients
hyperbilirubinemia
hyperuricemia
association with hemolysis
combination therapy trials
using peginterferon alfa-b/ribavirin
anorexia
ribavirin
chc patients
decreased appetite
increased blood lactic acid
hcv/hiv-coinfected patients
receiving peginterferon alfa-b/ribavirin
year-old man
sudden onset of diabetic ketoacidosis months after the start of treatment for hepatitis c.
elevated triglyceride levels
interferon alphas
dehydration
hypertriglyceridemia
diabetic ketoacidosis
postmarketing experience
anorexia
grades
grade
increased blood alkaline phosphatase
grades
melanoma patients
chc patients
hyperuricemia
anorexia
hypocalcemia
dehydration
appetite
appetite
increased blood lactic acid-uncommon
hyperglycemia
diabetes mellitus
new onset
worsening
hypertriglyceridemia-rare
diabetic ketoacidosis-frequency
elevated triglyceride levels-postmarketing reports
diabetesmelanoma patients
anorexia
increased blood alkaline phosphatase
chc patients
alopecia
rash
pruritus
dry skin
acquired lipodystrophy
sweating
herpes simplex
psoriasis
photosensitivity reaction
maculopapular rash
dermatitis
erythematous rash
eczema
night sweats
hyperhidrosis
acne
furuncle
erythema
urticaria
abnormal hair texture
nail disorder-uncommon
aggravated psoriasis
phototoxicity-rare
stevens-johnson syndrome
toxic epidermal necrolysis
erythema multiforme-frequency
generalized
exfoliative dermatitis
cutaneous desquamation
seborrhea
pigmentation disordermelanoma patients
exfoliative rash
alopecia
alopecia
ribavirin
rash
ribavirin
pruritus
ribavirin
dry skin
ribavirin
sweating
ribavirin
chc patients
acquired lipodystrophy
hcv/hiv-coinfected patients
receiving peginterferon alfa-b/ribavirin
urticaria
cutaneous desquamation of all of the patient
body
face
year-old man with chronic hepatitis c infection after months of combination
antiviral therapy with peginterferon alfa-b/ribavirin
ribavirin
topical corticosteroid therapy
significant improvement
weeks
alfa-b
significant improvement
decrease in cutaneous lesions
following week
interferon
development of systemic cutaneous lesions
pruritus
erythema multiforme
toxic epidermal necrolysis
stevens-johnson syndrome
urticaria
psoriasis
postmarketing experience
exfoliative rash
grades
grade
alopecia
grades
melanoma patients
chc patients
dyspnea
cough
pharyngitis
sinusitis
rhinitis
influenza
upper respiratory tract infection
bronchitis
dysphonia
epistaxis
respiratory disorder
respiratory tract congestion
sinus congestion
nasal congestion
rhinorrhea
upper airway secretion
pharyngolaryngeal pain
nonproductive cough-uncommon
emphysema
bronchiolitis obliterans
pleural effusion
lower respiratory tract infection-frequency
pulmonary infiltrates
pneumonitis
pneumonia
postmarketing reports
interstitial pneumonitis
pulmonary hypertensionmelanoma patients
dyspnea
cough
dyspnea
ribavirin
coughing
ribavirin
pharyngitis
ribavirin
sinusitis
ribavirin
rhinitis
ribavirin
chc patients
rhinitis
hcv/hiv-coinfected patients
receiving peginterferon alfa-b/ribavirin
pulmonary infiltrates
pneumonitis
pneumonia
use of peginterferon alfa-b
alpha interferon therapy in general
dyspnea
pulmonary infiltrates
pneumonia
bronchiolitis obliterans
postmarketing experience
dyspnea
grades
grade
cough
grades
grade
melanoma patients
chc patients
hyperbilirubinemia
hepatomegaly
ggt-frequency
increased risk of hepatic decompensation
death
hepatic decompensation
including fatalities
cirrhosismelanoma patients
increased alt
ast
increased ggt
hyperbilirubinemia
hyperuricemia
association with hemolysis
combination therapy trials
using peginterferon alfa-b/ribavirin
hepatomegaly
ribavirin
chc patients
increased ggt
cytolytic hepatitis
hcv/hiv-coinfected patients
receiving peginterferon alfa-b/ribavirin
hepatic decompensation
including fatalities
cirrhosis
study in hcv/hiv coinfection
increased risks of hepatic decompensation
death
patients with cirrhosis
increased alt
ast
grades
grade
ggt
grades
grade
melanoma patients
palpitations
cardiomyopathy
hypertension
hypotension
postmarketing experience
chc patients
palpitations
tachycardia
hypertension
cardiomyopathy
angina pectoris
pericardial effusion
supraventricular arrhythmias
vasculitis
myocardial infarction-rare
congestive heart failure
arrhythmia
cardiac ischemia-postmarketing reports
stroke
angina pectorismelanoma patients
myocardial infarction
bundle-branch block
ventricular tachycardia
supraventricular arrhythmia
chc patients
hypothyroidism
new onset
worsening
hyperthyroidism
new onset
worsening
frequency
thyroid-stimulating hormone
tsh
abnormalities
thyroid disorders-postmarketing reports
thyroiditismelanoma patients
endocrine disorders
hypothyroidism
hypothyroidism
ribavirin
hyperthyroidism
ribavirin
chc patients
tsh abnormalities
clinical manifestations
interferon therapies
conjunctivitis
ribavirin
vision
ribavirin
chc patients
ocular changes
treatment with this
other alpha interferons
loss of vision
retinopathy
macular edema
retinal hemorrhages
cotton wool spots
retinal artery
vein thrombosis
optic neuritis
papilledema
serous retinal detachment
chc patients
conjunctivitis
vision
visual disturbance
photophobia
eye irritation
lacrimal gland disorder
eye pain
dry eye
abnormal vision-uncommon
retinal ischemia
retinal artery
vein thrombosis/occlusion
blindness
visual acuity
optic neuritis
retinal exudates-rare
loss of visual acuity
visual fields
retinal hemorrhages
retinopathy
papilledema
macular edema-frequency
ocular changes
loss of vision
cotton wool spots
serous retinal detachmentmelanoma patients
serious retinal disorders
visual disturbances
vision
reduction in visual acuity-frequency
partial loss of vision
retinal thrombosis
retinopathy
chc patients
menstrual disorder
frequent micturition
polyuria
urine abnormality
amenorrhea
menorrhagia
ovarian disorder
vaginal disorder
sexual dysfunction
prostatitis
erectile dysfunction/impotencemelanoma patients
proteinuria
menstrual disorder
ribavirin
chc patients
proteinuria
grades
melanoma patients
autoimmune thrombocytopenia
been reported weeks after the start of treatment for hepatitis c.
case report of hashimoto encephalopathy
use of peginterferon alfa-b/ribavirin for chronic hepatitis c infection in a
year-old woman with a
year history of autoimmune thyroiditis
discontinuation of the drugs
corticosteroid therapy
patient
full recovery
sarcoidosis
postmarketing experience
chc patients
lupus-like syndrome
exacerbation of sarcoidosis-frequency
exacerbation of autoimmune disorders
autoimmune hepatitis
development of binding antibodies
including
neutralizing antibodies
peginterferon alfa-b
autoimmune thrombocytopenia
hashimoto
encephalopathy-postmarketing reports
systemic lupus erythematosus
vogt-koyanagi-harada syndrome
serious acute hypersensitivity reactions
use of alpha interferon therapy
chc patients
drug hypersensitivity-rare
serious acute hypersensitivity reactions-postmarketing reports
acute hypersensitivity reactions
including anaphylaxis
angioedema
bronchoconstriction
urticaria
anaphylactic reactions
including
anaphylactic shock
renal insufficiency
renal failure
interstitial nephritis
postmarketing experience
chc patients
interstitial nephritis-rare
renal insufficiency
renal failure
side effects of peginterferon alfa-b
fda
healthcare professional for medical advice
stomach pain
anxiety
black, tarry stools
blood in the urine
stools
bloody diarrhea
chills
cloudy urine
cough or hoarseness
depression
breathing
fever
irritability
side pain
mood swings
nausea
difficult urination
pale skin
red spots on the skin
tightness in the chest
trouble sleeping
troubled breathing with exertion
unusual bleeding
bruising
unusual tiredness
weakness
vomiting
changes in menstrual cycle
constipation
drowsiness
dry hair
skin
sensitivity to cold
weight gain
aching
pain
stiffness in the joints
aggressive behavior
attempt
backache
chest pain (severe)
cool, pale skin
decrease in vision
diarrhea
difficulty with speaking
dizziness
drug addiction
overdose
eye pain
irregular heartbeat
feeling of constant movement of self
surroundings
headache
loss of appetite
muscle weakness
nervousness
numbness
loss of feeling
limbs on the same side of the body
palpitations
paralysis
possible decrease in the amount of urine
rash
hives
itching
restlessness
sensation of spinning
sensitivity to heat
sensitivity to sunlight
sweating (excessive)
thick, scaly skin
thoughts
killing someone
thoughts
killing
moist skin
weight loss
aching
fullness
tension in the sinuses
bruising
irritation
itching at the injection site
burning
crawling
itching
numbness
prickling
pins
needles
tingling feelings
change in taste
difficulty with moving
flushing of the skin
hair loss
indigestion
loss of taste
muscle pain
stiffness
pain in the bones
muscles
runny nose
sneezing
sore throat
thinning of the hair
muscle rigidity
stiffness